CELC ▼ -3.6% - Celcuity Inc.
$CELC - Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
24-OCT-2026 04:15 AM ET
Share this post
More filings for $CELC
CELC ▲ +0.4% - Celcuity Inc.Oct 23, 2026CELC ▼ -0.1% - Celcuity Inc.Oct 5, 2026CELC ▲ +0.9% - Celcuity Inc.Oct 2, 2026CELC ▲ +4.0% - Celcuity Inc.Sep 30, 2026CELC ▲ +1.1% - Celcuity Inc.Sep 17, 2026CELC ▼ -0.2% - Celcuity Inc.Sep 1, 2026
View full $CELC filing history →💬 Comments
Loading comments…
Leave a comment